Literature DB >> 16755312

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

B R Hemmelgarn1, Finlay A McAlister, Steven Grover, Martin G Myers, Donald W McKay, Peter Bolli, Carl Abbott, Ernesto L Schiffrin, George Honos, Ellen Burgess, Karen Mann, Thomas Wilson, Brian Penner, Guy Tremblay, Alain Milot, Arun Chockalingam, Rhian M Touyz, Sheldon W Tobe.   

Abstract

OBJECTIVE: To provide updated, evidence-based recommendations for the diagnosis and assessment of adults with high blood pressure. OPTIONS AND OUTCOMES: For persons in whom a high blood pressure value is recorded, a diagnosis of hypertension is dependent on the appropriate measurement of blood pressure, the level of the blood pressure elevation, the approach used to monitor blood pressure (office, ambulatory or home/self), and the duration of follow-up. In addition, the presence of cardiovascular risk factors and target organ damage should be assessed to determine the urgency, intensity and type of treatment. For persons diagnosed as having hypertension, estimating the overall risk of adverse cardiovascular outcomes requires an assessment for other vascular risk factors and hypertensive target organ damage. EVIDENCE: MEDLINE searches were conducted from November 2004 to October 2005 to update the 2005 recommendations. Reference lists were scanned, experts were polled, and the personal files of the authors and subgroup members were used to identify other studies. Identified articles were reviewed and appraised using prespecified levels of evidence by content and methodological experts. As per previous years, the authors only included studies that had been published in the peer-reviewed literature and did not include evidence from abstracts, conference presentations or unpublished personal communications. RECOMMENDATIONS: The present document contains recommendations for blood pressure measurement, diagnosis of hypertension, and assessment of cardiovascular risk for adults with high blood pressure. These include the accurate measurement of blood pressure, criteria for the diagnosis of hypertension and recommendations for follow-up, assessment of overall cardiovascular risk, routine and optional laboratory testing, assessment for renovascular and endocrine causes, home and ambulatory blood pressure monitoring, and the role of echocardiography for those with hypertension. Key features of the 2006 recommendations include continued emphasis on an expedited diagnosis of hypertension, an in-depth review of the role of global risk assessment in hypertension therapy, and the use of home/self blood pressure monitoring for patients with masked hypertension (subjects with hypertension who have a blood pressure that is normal in clinic but elevated on home/self measurement). VALIDATION: All recommendations were graded according to the strength of the evidence and were voted on by the 45 members of the Canadian Hypertension Education Program Evidence-Based Recommendations Task Force. All recommendations reported herein received at least 95% consensus. These guidelines will continue to be updated annually.

Entities:  

Mesh:

Year:  2006        PMID: 16755312      PMCID: PMC2560864          DOI: 10.1016/s0828-282x(06)70279-3

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  31 in total

Review 1.  A novel process for updating recommendations for managing hypertension: rationale and methods.

Authors:  K B Zarnke; N R Campbell; F A McAlister; M Levine
Journal:  Can J Cardiol       Date:  2000-09       Impact factor: 5.223

2.  Primary and subsequent coronary risk appraisal: new results from the Framingham study.

Authors:  R B D'Agostino; M W Russell; D M Huse; R C Ellison; H Silbershatz; P W Wilson; S C Hartz
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

3.  The rudimentary phase of personalised medicine: coronary risk scores.

Authors:  Eric J Topol; Michael S Lauer
Journal:  Lancet       Date:  2003-11-29       Impact factor: 79.321

4.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

5.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

Review 6.  What is the white-coat effect and how should it be measured?

Authors:  Thomas G Pickering; William Gerin; Amy R Schwartz
Journal:  Blood Press Monit       Date:  2002-12       Impact factor: 1.444

7.  Distribution of blood pressure and hypertension in Canada and the United States.

Authors:  M R Joffres; P Hamet; D R MacLean; G J L'italien; G Fodor
Journal:  Am J Hypertens       Date:  2001-11       Impact factor: 2.689

Review 8.  The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.

Authors:  K B Zarnke; M Levine; F A McAlister; N R Campbell; M G Myers; D W McKay; P Bolli; G Honos; M Lebel; K Mann; T W Wilson; C Abbott; S Tobe; E Burgess; S Rabkin
Journal:  Can J Cardiol       Date:  2001-12       Impact factor: 5.223

9.  The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.

Authors:  Finlay A McAlister; Kelly B Zarnke; Norman R C Campbell; Ross D Feldman; Mitchell Levine; Jeff Mahon; Steven A Grover; Richard Lewanczuk; Frans Leenen; Sheldon Tobe; Marcel Lebel; James Stone; Ernesto L Schiffrin; Simon W Rabkin; Richard I Ogilvie; Pierre Larochelle; Charlotte Jones; George Honos; George Fodor; Ellen Burgess; Pavel Hamet; Robert Herman; Jane Irvine; Bruce Culleton; James M Wright
Journal:  Can J Cardiol       Date:  2002-06       Impact factor: 5.223

10.  The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Authors:  Nadia A Khan; Finlay A McAlister; Norman R C Campbell; Ross D Feldman; Simon Rabkin; Jeff Mahon; Richard Lewanczuk; Kelly B Zarnke; Brenda Hemmelgarn; Marcel Lebel; Mitchell Levine; Carol Herbert
Journal:  Can J Cardiol       Date:  2004-01       Impact factor: 5.223

View more
  25 in total

Review 1.  Masked hypertension: a common but insidious presentation of hypertension.

Authors:  D W McKay; Martin G Myers; Peter Bolli; Arun Chockalingam
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

2.  Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines.

Authors:  Lizebeth Cox; Marita Kloseck; Richard Crilly; Carol McWilliam; Laura Diachun
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

Review 3.  The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk.

Authors:  Robert R Quinn; Brenda R Hemmelgarn; Raj S Padwal; Martin G Myers; Lyne Cloutier; Peter Bolli; Donald W McKay; Nadia A Khan; Michael D Hill; Jeff Mahon; Daniel G Hackam; Steven Grover; Thomas Wilson; Brian Penner; Ellen Burgess; Finlay A McAlister; Maxime Lamarre-Cliche; Donna McLean; Ernesto L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Arun Chockalingam; Simon W Rabkin; Martin Dawes; Rhian M Touyz; Kevin D Burns; Marcel Ruzicka; Norman R C Campbell; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2010-05       Impact factor: 5.223

Review 4.  Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions.

Authors:  J David Spence
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

5.  Adding "value" to clinical practice guidelines.

Authors:  James P McCormack; Peter Loewen
Journal:  Can Fam Physician       Date:  2007-08       Impact factor: 3.275

6.  Hypertension treatment and control rates: chart review in an academic family medicine clinic.

Authors:  Sara J Houlihan; Scot H Simpson; Andrew J Cave; Nigel W Flook; Mary E Hurlburt; Chris J Lord; Linda L Smith; Harvey H Sternberg
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

7.  Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina.

Authors:  Adolfo Rubinstein; Lisandro Colantonio; Ariel Bardach; Joaquín Caporale; Sebastián García Martí; Karin Kopitowski; Andrea Alcaraz; Luz Gibbons; Federico Augustovski; Andrés Pichón-Rivière
Journal:  BMC Public Health       Date:  2010-10-20       Impact factor: 3.295

8.  Assessment of the Siksika chronic disease nephropathy-prevention clinic.

Authors:  David R R Ward; Ellen Novak; Nairne Scott-Douglas; Sony Brar; Melvin White; Brenda R Hemmelgarn
Journal:  Can Fam Physician       Date:  2013-01       Impact factor: 3.275

9.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

Authors:  Thomas G Pickering; Nancy Houston Miller; Gbenga Ogedegbe; Lawrence R Krakoff; Nancy T Artinian; David Goff
Journal:  Hypertension       Date:  2008-05-22       Impact factor: 10.190

10.  Regulation of the epithelial sodium channel [ENaC] in kidneys of salt-sensitive Dahl rats: insights on alternative splicing.

Authors:  Marlene F Shehata
Journal:  Int Arch Med       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.